Dominant Lethal Pathologies in Male Mice Engineered to Contain an X-Linked DUX4 Transgene-Reference-Cited by-同舟云学术

Dominant Lethal Pathologies in Male Mice Engineered to Contain an X-Linked DUX4 Transgene

Published:2014-09 Issue:5 Volume:8 Page:1484-1496
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Dandapat Abhijit,Bosnakovski Darko,Hartweck Lynn M.,Arpke Robert W.,Baltgalvis Kristen A.,Vang Derek,Baik June,Darabi Radbod,Perlingeiro Rita C.R.,Hamra F. Kent,Gupta Kalpna,Lowe Dawn A.,Kyba Michael

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference59 articles.

1. Second-generation tetracycline-regulatable promoter: repositioned tet operator elements optimize transactivator synergy while shorter minimal promoter offers tight basal leakiness;Agha-Mohammadi;J. Gene Med.,2004

2. A new immuno-, dystrophin-deficient model, the NSG-mdx(4Cv) mouse, provides evidence for functional improvement following allogeneic satellite cell transplantation;Arpke;Stem Cells,2013

3. The FSHD-linked locus D4F104S1 (p13E-11) on 4q35 has a homologue on 10qter;Bakker;Muscle Nerve Suppl.,1995

4. Wnt/β-catenin signaling suppresses DUX4 expression and prevents apoptosis of FSHD muscle cells;Block;Hum. Mol. Genet.,2013

5. An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies;Bosnakovski;EMBO J.,2008

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flavones provide resistance to DUX4-induced toxicity via an mTor-independent mechanism;Cell Death & Disease;2023-11-16

2. MATR3 is an endogenous inhibitor of DUX4 in FSHD muscular dystrophy;Cell Reports;2023-09

3. Molecular and Phenotypic Changes in FLExDUX4 Mice;Journal of Personalized Medicine;2023-06-25

4. Flavones provide resistance to DUX4-induced toxicity via an mTor-independent mechanism;2023-02-02

5. Transplantation of PSC-derived myogenic progenitors counteracts disease phenotypes in FSHD mice;npj Regenerative Medicine;2022-09-02